Explore

Cell and Gene Therapy USA 2018

Cell and Gene Therapy Strategy Meeting USA 2018

Boston, United States
12 June 2018
The conference ended on 12 June 2018

Important Dates

Abstract Submission Deadline
12th June 2018

About Cell and Gene Therapy USA 2018

The Cell and Gene Therapy Roundtable Discussions Strategy Meeting is free to attend for qualified end-users.These include Senior Executives of Cell and Gene Therapy (from medium to large Pharma, Biopharma and Biotech players) as well as thought leaders from Academia and regulatory authorities

Topics

Biotherapeutics, Car-t, Immune deficiencies, Cellular immunotherapy, Cell engineering, And manufacturing.

Call for Papers

Proventa International will be gathering over 100 C-Level Directors from a mix of emerging to large Pharmaceutical, Biotechnology & Academic/Research Institutions to help solve their key strategic challenges in the area of Cell and Gene Therapy.

The Cell and Gene Therapy Roundtable Discussions Strategy Meeting is free to attend for qualified end-users.These include Senior Executives of Cell and Gene Therapy (from medium to large Pharma, Biopharma and Biotech players) as well as thought leaders from Academia and regulatory authorities

Thought leaders who will benefit from attending include Chief Executive Officer, Chief Scientific Officer, SVPs, EVPs, VPs, Executive Director, Director and Global Head responsible for:

– Cell Therapy, Cell Engineering, Biotherapeutics, Regenerative Medicine, Immune Deficiencies, CAR-T, Cellular Immunotherapy, Supply Chain, and Manufacturing.

Register now and Book your seat. Limited slots only.

Keep Up to Date with PaperCrowd

Sign up and follow your favorite conferences.

We are no longer accepting conference submissions on PaperCrowd. We apologise for any inconvenience.